Clinical Trials Directory

Trials / Completed

CompletedNCT01616069

Assessment of Hemodynamic Response in Cardiopulmonary Bypass Graft After Cardiopulmonary Bypass Using Transesophegeal Echocardiography

Assessment and Hemodynamic Response in CABG After Cardiopulmonary Bypass Using Intraoperative Transesophegeal Echocardiography

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
81 (actual)
Sponsor
Federal University of Juiz de Fora · Academic / Other
Sex
All
Age
45 Years – 65 Years
Healthy volunteers
Not accepted

Summary

This is a double blind randomization study, assessing hemodynamic response in patients who underwent a cardiopulmonary bypass graft (CABG) with cardiopulmonary bypass (CPB) using intraoperative trasnesophageal echocardiography (TEE) to know what inotropic drug will be batter to improve the heart function. Epinephrine, milrinone, dobutamine and levosimendan will be assessment.

Conditions

Interventions

TypeNameDescription
DRUGepinephrine and levosimendanepinephrine (0,06mcg/kg/min), levosimendan (0,2 mcg/kg/min)

Timeline

Start date
2012-02-01
Primary completion
2012-02-01
Completion
2013-12-01
First posted
2012-06-11
Last updated
2015-06-02

Locations

1 site across 1 country: Brazil

Source: ClinicalTrials.gov record NCT01616069. Inclusion in this directory is not an endorsement.

Assessment of Hemodynamic Response in Cardiopulmonary Bypass Graft After Cardiopulmonary Bypass Using Transesophegeal Ec (NCT01616069) · Clinical Trials Directory